A candidate regulatory variant at the TREM gene cluster associates with decreased Alzheimer's disease risk and increased TREML1 and TREM2 brain gene expression.

Alzheimers Dement
Authors
Abstract

INTRODUCTION: We hypothesized that common Alzheimer's disease (AD)-associated variants within the triggering receptor expressed on myeloid (TREM) gene cluster influence disease through gene expression.

METHODS: Expression microarrays on temporal cortex and cerebellum from ∼400 neuropathologically diagnosed subjects and two independent RNAseq replication cohorts were used for expression quantitative trait locus analysis.

RESULTS: A variant within a DNase hypersensitive site 5' of TREM2, rs9357347-C, associates with reduced AD risk and increased TREML1 and TREM2 levels (uncorrected P = 6.3 Ã— 10(-3) and 4.6 Ã— 10(-2), respectively). Meta-analysis on expression quantitative trait locus results from three independent data sets (n = 1006) confirmed these associations (uncorrected P = 3.4 Ã— 10(-2) and 3.5 Ã— 10(-3), Bonferroni-corrected P = 6.7 Ã— 10(-2) and 7.1 Ã— 10(-3), respectively).

DISCUSSION: Our findings point to rs9357347 as a functional regulatory variant that contributes to a protective effect observed at the TREM locus in the International Genomics of Alzheimer's Project genome-wide association study meta-analysis and suggest concomitant increase in TREML1 and TREM2 brain levels as a potential mechanism for protection from AD.

Year of Publication
2016
Journal
Alzheimers Dement
Date Published
2016 Dec 08
ISSN
1552-5279
DOI
10.1016/j.jalz.2016.10.005
PubMed ID
27939925
Links
Grant list
R01 AG032990 / AG / NIA NIH HHS / United States
R01 NS080820 / NS / NINDS NIH HHS / United States
RF1 AG051504 / AG / NIA NIH HHS / United States
U01 AG046139 / AG / NIA NIH HHS / United States